User login
Total Therapy III, a combination treatment regimen of chemotherapy and radiation, is now commonly administered to patients with acute lymphoblastic leukemia. But this was not always the case.
In an interview with National Public Radio, childhood ALL patients James Eversull and Pat Patchell, now among the oldest of St. Jude Children’s Research Hospital’s leukemia survivors, reflect on their experiences with the once-experimental treatment.
Read and listen to the full interview at npr.org.
Total Therapy III, a combination treatment regimen of chemotherapy and radiation, is now commonly administered to patients with acute lymphoblastic leukemia. But this was not always the case.
In an interview with National Public Radio, childhood ALL patients James Eversull and Pat Patchell, now among the oldest of St. Jude Children’s Research Hospital’s leukemia survivors, reflect on their experiences with the once-experimental treatment.
Read and listen to the full interview at npr.org.
Total Therapy III, a combination treatment regimen of chemotherapy and radiation, is now commonly administered to patients with acute lymphoblastic leukemia. But this was not always the case.
In an interview with National Public Radio, childhood ALL patients James Eversull and Pat Patchell, now among the oldest of St. Jude Children’s Research Hospital’s leukemia survivors, reflect on their experiences with the once-experimental treatment.
Read and listen to the full interview at npr.org.